ARCHIVES

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

Ovariectomy Without HRT Increases Death Rate

September 29, 2006

European Commission Approves Subcutaneous Rituximab

March 28, 2014

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

ACCC Asks More Community Representation, Clear Separation From Centers In New NCI Division

June 29, 1979

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

Anil Potti Joins Myrtle Beach Private Practice.

June 3, 2011